Cutaneous mastocytosis (CM) has a low incidence of systemic involvement in children, whereas, systemic mastocytosis (SM) occurs in greater than 25% of adults with CM (Hartmann & Metcalfe ...

The following is a summary of “Comparison of prognostic scores according to WHO classification in 170 patients with advanced mastocytosis and C-finding treated with midostaurin,” published in the ...

Sudipto Mukherjee, MD, PhD, MPH, of Cleveland Clinic, describes the steps clinicians should take when they encounter clinical abnormalities that may point to systemic mastocytosis. (1:48 ...

Here’s what else the team learned. In Systemic Mastocytosis, What’s the Impact of Type I Interferon Autoantibodies? Investigators from the National Institutes of Health recently tackled the ...

Blueprint Medicines' AYVAKIT continues to gain traction among key stakeholders. See more on BPMC stock and the factors ...

Cogent Biosciences' uncertain competitive edge may compel investors to sit on the sidelines. Read more about the cautious ...

A new analysis of data from the PATHFINDER study confirms that avapritinib offers efficacy and a favorable risk-benefit profile for patients with advanced systemic mastocytosis (AdvSM). The analysis ...

Interferon alpha-2b (aggressive forms of mastocytosis). Chemotherapy (aggressive systemic mastocytosis). Local radiation for bone pain. Low-dose aspirin is helpful in some patients, because it ...

If you're coping with episodic facial flushing you may be frustrated at how hard it is to get a diagnosis. What is facial flushing related to mastocytosis like and what are some of the conditions ...

The discussion also covered the company's expectations for pivotal trials, which are anticipated to yield results for three different indications: advanced systemic mastocytosis (AdvSM ...

Gastrocrom (cromolyn sodium) is a prescription drug used to treat mastocytosis. Gastrocrom comes as a concentrate liquid solution you take by mouth. It’s typically taken four times per day.